NuSkin Enterprises, Inc. (NUS) — 分析摘要
NuSkin Enterprises, Inc.（NUS）的市值为255.86百万美元，最近一年的营收同比增长了-14.3%。净利润率为10.8%。当前市盈率为4.7倍。
核心要点
- 营收同比变化-14.3%
- 净利润率10.8%
- 市盈率4.7倍
与WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES板块的其他公司相比，NUS的营收增长为-14.3%，市盈率为4.7倍。
NuSkin Enterprises, Inc. (NUS)
更新 — ET · 来源 POLYGON
红旗与风险提示重点关注
当前存在需要关注的风险信号，应与估值结果一并解读。
净利润较上一期下降 66.0%。
Nu Skin Enterprises Inc develops and distributes a comprehensive line of beauty and wellness solutions in various countries. The company operates in two primary product categories: beauty and wellness products. Additionally, the company also operates through its subsidiary, Rhyz. It reports revenue from nine segments, consisting of its seven geographic Nu Skin segments: Americas, Southeast Asia/Pacific, Mainland China, Japan, Europe & Africa, South Korea, and Hong Kong/Taiwan and two Rhyz segments: manufacturing, which includes manufacturing and packaging subsidiaries it has acquired; and Rhyz Other, which includes other investments by its Rhyz strategic investment arm. The majority of the company's revenue is generated from the Wellness product category from the Americas segment.
行业
WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES
员工人数
8,600
总部
PROVO, UT
Exchange
XNYS
基于 4 年财务数据的系统性竞争优势评估
此评估基于历史财务数据的量化分析，不构成投资建议。护城河评级可能随行业和竞争环境变化。
首版展示近期 SEC Forms 3、4、5 备案活动。尚未解析单笔买入/卖出交易。
资本结构
现金流
年度每股股息
$0.24
股息收益率
4.83%
股息历史
免责声明：本站内容不构成投资建议。数据来源于SEC EDGAR和Polygon.io。过往业绩不代表未来表现。投资决策前请自行研究。